Despite their effectiveness, GLP-1 RAs have several negative gastrointestinal side effects, including nausea, vomiting, diarrhea, pancreatitis, bowel obstruction, and notably gastroparesis, which is associated with small intestinal bacterial overgrowth (SIBO) [6,7]. This evidence concerns the gene GCG and gastroparesis.